HAE Haemonetics Corporation
Company Analysis
Latest News
🟢 Haemonetics is trading 4.4% up today after BofA raised its price target to $100
Haemonetics is trading 4.4% higher at $91.06 after BofA Securities raised its price target to $100 from $93 on August 12, 2026; the source does not explicitly...
🟢 Haemonetics is trading 5% up today after earnings beat and raised FY2027 guidance
Haemonetics is trading 5% up now at $87.79 after reporting first-quarter fiscal 2027 revenue of $339.4 million and adjusted EPS of $1.14, exceeding the $1.07...
Haemonetics' first quarter revenue grew 5.6% to $339.4M, prompting a raise in FY2027 guidance.
Haemonetics reported first quarter fiscal 2027 revenue of $339.4 million, an increase of 5.6% year-over-year, and adjusted earnings per share of $1.14, up...
Haemonetics Corporation Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Haemonetics is expected to report Q2 2026 revenue of $327.9 million and earnings per share of $1.07, with the current stock price of $85.54 trading close to...
Haemonetics Appoints Martin Madaus to Board; Shareholders Approve Expanded Incentive Plan
Haemonetics announced the election of Dr. Martin Madaus to its Board of Directors, effective July 24, 2026. Concurrently, following its 2026 annual shareholder...
🟢 Haemonetics is trading 4.1% up today amid broad healthcare sector strength
Haemonetics is trading 4.1% up at $83.16 as the stock outperforms the broader market amid a strong move across healthcare peers. • There are no fresh...
🟢 Haemonetics is trading 4.2% up today amid a broad healthcare sector rally
Haemonetics is trading 4.2% up at $79.92 as the stock moves in tandem with a broad healthcare sector rally. • The upward momentum is driven by strong earnings...